Literature DB >> 1972631

Structure and polymorphic map of human lipoprotein lipase gene.

K Oka1, G T Tkalcevic, T Nakano, H Tucker, K Ishimura-Oka, W V Brown.   

Abstract

Lipoprotein lipase (LPL) catalyzes the key step for the removal of triacylglycerol-rich lipoproteins from the circulation. In this paper, we report the cloning and structure of the normal human LPL gene, which was isolated in three overlapping lambda phage clones that span about 35 kilo bases (kb) of the genetic locus. The peptide coding region of the gene is approx. 23 kb in length and contains nine exons with intron sizes ranging from 0.7 to 8.7 kb. The entire 3' untranslated region is in the tenth exon. Specific sequences in this region support the hypothesis that two mRNA species found for human LPL are generated by differential utilization of polyadenylation signals. The first exon occurs in the 5' untranslated region and the region coding for the signal peptide. The second exon includes the protein domain coding for the N-linked glycosylation site that is required for the expression of enzyme activity. The fourth exon contains the region that was proposed as a lipid binding domain, the sixth for one putative heparin binding domain, and the eighth codes for a domain containing another N-linked glycosylation site. These results suggest that the unique structural and functional domains are confined to specific exons. The PvuII polymorphic site was located within the intron between exon 6 and 7 and the HindIII polymorphic site to the 3' flanking region. The location of these polymorphic sites suggests that the PvuII restriction fragment length polymorphism (RFLP) associated with lipase deficiency in a few Japanese kindred may be a linkage marker for a functional defect of LPL, while the HindIII RFLP associated with hypertriglyceridemia may be important for gene regulation of LPL.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972631     DOI: 10.1016/0167-4781(90)90079-h

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  A multilocus genotyping assay for candidate markers of cardiovascular disease risk.

Authors:  S Cheng; M A Grow; C Pallaud; W Klitz; H A Erlich; S Visvikis; J J Chen; C R Pullinger; M J Malloy; G Siest; J P Kane
Journal:  Genome Res       Date:  1999-10       Impact factor: 9.043

Review 2.  Regulation of the synthesis, processing and translocation of lipoprotein lipase.

Authors:  J E Braun; D L Severson
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

3.  Role of candidate genes in the lipid responses to intensified treatment in Type 2 diabetes.

Authors:  O Ukkola; J Salonen; Y Antero Kesäniemi
Journal:  J Endocrinol Invest       Date:  2005-11       Impact factor: 4.256

4.  HindIII-polymorphism in the LPL-gene detected by PCR.

Authors:  T Bruin; P W Reymer; B E Groenemeyer; P J Talmud; J J Kastelein
Journal:  Nucleic Acids Res       Date:  1991-11-25       Impact factor: 16.971

5.  A missense mutation (Trp86----Arg) in exon 3 of the lipoprotein lipase gene: a cause of familial chylomicronemia.

Authors:  K Ishimura-Oka; F Faustinella; S Kihara; L C Smith; K Oka; L Chan
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

6.  Lipoprotein lipase gene HindIII polymorphism and risk of myocardial infarction in South Indian population.

Authors:  Parthasaradhi Reddy Tanguturi; Bhoomireddy Pullareddy; B S Rama Krishna; Dwarkanath K Murthy
Journal:  Indian Heart J       Date:  2013-11-13

7.  Dinucleotide repeat polymorphisms at the lipoprotein lipase (LPL) locus.

Authors:  T M Narcisi; M C Schotz; J Scott; C C Shoulders
Journal:  Hum Genet       Date:  1993-10-01       Impact factor: 4.132

8.  Heterogeneous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency.

Authors:  T Gotoda; N Yamada; M Kawamura; K Kozaki; N Mori; S Ishibashi; H Shimano; F Takaku; Y Yazaki; Y Furuichi; T Murase
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

9.  W (A or T) sequences as probes and primers suitable for genomic mapping and fingerprinting.

Authors:  R Drmanac; D Nizetic; G G Lennon; A Beitverda; H Lehrach
Journal:  Nucleic Acids Res       Date:  1991-11-11       Impact factor: 16.971

10.  Molecular studies on primary lipoprotein lipase (LPL) deficiency. One base deletion (G916) in exon 5 of LPL gene causes no detectable LPL protein due to the absence of LPL mRNA transcript.

Authors:  A Takagi; Y Ikeda; Z Tsutsumi; T Shoji; A Yamamoto
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.